Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Average Price Target from Brokerages
Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fifteen ...
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...
Taysha Gene Therapies: Promising Developments and Strategic Investment Opportunity
Gil Blum, an analyst from Needham, maintained the Buy rating on Taysha Gene Therapies (TSHA – Research Report). The associated price target ...
Viking Therapeutics among potential buyout candidates: Oppenheimer
Ahead of the 2025 J.P. Morgan Healthcare Conference scheduled to take place in a few days, Oppenheimer named five potential buyout candidates in biotech on Friday, naming obesity drug developer Viking ...
Opco lists five potential biotech targets into JPMorgan conference
Oppenheimer laid out five “aspirational” potential takeover targets in biotech heading into the annual JPMorgan Health Care Conference. “We ...